stockportfolio.pro
Stocks / ABT vs CVS
ABT vs CVS
Abbott Laboratories and CVS Health Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Abbott Laboratories (ABT) | CVS Health Corporation (CVS) | |
|---|---|---|
| Market cap | $154.4B | $128.5B |
| Revenue (latest FY) | $44.33B | $402.07B |
| Net income (latest FY) | $6.52B | $1.77B |
| Revenue growth (5y CAGR) | 5.1% | 8.4% |
| Net margin | 14.7% | 0.4% |
| Return on equity | 12.5% | 2.4% |
| P/E ratio | 24.7 | 44.2 |
| Dividend yield | 2.9% | 2.6% |
| Profitable years (of last 10) | 10 | 9 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ABT — free Open CVS — freeFrequently asked questions
Which is bigger, ABT or CVS?
Abbott Laboratories is larger by market capitalization — $154.4B versus $128.5B.
Which grows faster, ABT or CVS?
Over the last five fiscal years, CVS Health Corporation grew revenue faster — 8.4%/yr versus 5.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.